article thumbnail

Mickey Mouse to Enter Public Domain in 2024

IPilogue

Every year on January 1, works protected under copyright law enter into the public domain due to their copyright protection expiring. As a result, the Mickey Mouse copyright was then set to expire at the end of 2003. Serena Nath is an IPilogue Writer and a 2L JD candidate at Osgoode Hall Law School.

article thumbnail

3 Count: Extrinsic vs. Intrinsic

Plagiarism Today

First off today, Massimo Capizza at the National Law Review reports that the Supreme Court of the United States has denied certiorari in a case over the 2003 Josh Groban song You Raise Me Up , leaving a circuit split in place over how to determine substantial similarity between two works. Let me know via Twitter @plagiarismtoday.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Civil War Letters Still Copyrighted?

Dear Rich IP Blog

If I can determine that said letters have been on display at those libraries since before 1927, can I conclude that the first publication occurred before 1927, thus placing them in the public domain ? Divide your letters into three categories: Unpublished letters as of January 1, 2003.

article thumbnail

Mickey Mouse to Enter Public Domain in 2024

IPilogue

Every year on January 1, works protected under copyright law enter into the public domain due to their copyright protection expiring. As a result, the Mickey Mouse copyright was then set to expire at the end of 2003. The post Mickey Mouse to Enter Public Domain in 2024 appeared first on IPOsgoode.

article thumbnail

Section 22 Vs Section 26 And Section 27: The Contrasting Sections Of Copyright Law

IP and Legal Filings

, “Does the author of any such work loses every right in terms of Copyright after the expiration of the time period mentioned under Section(s) 22, 26 and 27 and have no recourse to the same since the works are in public domain thereafter?”. The works will enter the public domain ultimately.

article thumbnail

New SPC referral to the CJEU on the interpretation of Art 3(a) and (c) for combination products (Merck v Clonmel)

The IPKat

Ezetimibe was originally marketed as a monotherapy, EZETROL, and an Irish SPC (SPC 2003/014) was granted for EZETROL following its approval. Case Background: Merck v Clonmel The Irish case related to Merck's SPC for its combination product INEGY, which contains the active ingredients ezetimibe and simvastatin.

Art 117
article thumbnail

Understanding Freedom to Operate (FTO) Concerning IP & Patents

Kashishipr

Three pharmaceutical companies, including Enzon Pharmaceuticals, Micromet AG, and Cambridge Antibody Technology (now acquired by AstraZeneca), in September 2003 announced signing a non-exclusive cross-license agreement. In the latter case, no license or permission of any sort is required from the patent owner for commercializing the product.

IP 105